Against the backdrop of increased public health awareness, inorganic nanomaterials have
been widely explored as promising nanoagents for various kinds of biomedical applications …

Progress in the field of precision medicine has changed the landscape of cancer therapy.
Precision medicine is propelled by technologies that enable molecular profiling, genomic …

Clinical immunotherapy of solid tumors elicits durable responses only in a minority of
patients, largely due to the highly immunosuppressive tumor microenvironment (TME) …

Sonodynamic therapy (SDT) has been a promising therapeutic modality for cancer because
of its superior advantages compared with other therapeutic strategies. However, the current …

Multi-drug resistance (MDR) in cancer cells, either intrinsic or acquired through various
mechanisms, significantly hinders the therapeutic efficacy of drugs. Typically, the reduced …

Cancer immunotherapy efficacy is largely limited by the suppressive tumor immune
microenvironment (TIME) where antitumor immune cells are inhibited and tumor antigens …

Traditional cancer therapeutics have been criticized due to various adverse effects and
insufficient damage to targeted tumors. The breakthrough of nanoparticles provides a novel …

Two-dimensional layered double hydroxides (LDHs) are currently a topic of significant
interest due to their extraordinary physiochemical properties. LDHs are potentially useful in …

Cancer has complex pathophysiology and is one of the primary causes of death and
morbidity across the world. Chemotherapy, targeted therapy, radiation therapy, and …

Cancer continues to represent a global health concern, imposing an ongoing need to
research for better treatment alternatives. In this context, nanomedicine seems to be the …